申请人:Chaimbault Corinne
公开号:US20090203747A1
公开(公告)日:2009-08-13
The present invention relates to the field of pharmacy, especially the treatment of neurodegenerative diseases. The invention specifically relates to a family of chemical compounds for which a neuroprotective activity has been demonstrated.
Given that certain members of said family are novel compounds which have never been described, the invention relates to said novel products, the synthesis method thereof and certain novel intermediate synthesis products.
The present invention further relates to compositions comprising the compounds of said family, and the use of said compounds as medicaments, especially for the preparation of a medicament for the treatment of neurodegenerative diseases.
本发明涉及制药领域,特别是神经退行性疾病的治疗。本发明特别涉及一类已经证明具有神经保护活性的化合物家族。鉴于该家族的某些成员是尚未被描述的新化合物,本发明涉及这些新产品、其合成方法和某些新的中间合成产品。本发明还涉及包含该家族化合物的组合物,以及将该化合物用作药物,特别是用于制备治疗神经退行性疾病的药物。